Â鶹´«Ã½

    Advertisement

    We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!

    In the last 7 days
    Pharmacy Times04:07 19-Dec-24
    Center for Biosimilars01:52 19-Dec-24
    Korea JoongAng Daily20:12 18-Dec-24
    Korea Biomedical Review16:58 18-Dec-24
    PR Newswire (Press Release)14:55 18-Dec-24
    JD Supra03:58 18-Dec-24
    The Korea Herald17:29 17-Dec-24
    Korea JoongAng Daily17:14 17-Dec-24
    Korea Biomedical Review15:58 17-Dec-24
    JD Supra06:23 17-Dec-24
    Center for Biosimilars05:21 17-Dec-24
    JD Supra04:31 17-Dec-24
    Korea JoongAng Daily20:26 16-Dec-24
    Korea Biomedical Review13:37 16-Dec-24
    Business Wire (Press Release)10:38 16-Dec-24
    In the last month
    Center for Biosimilars23:15 14-Dec-24
    Korea JoongAng Daily15:31 13-Dec-24
    Korea Biomedical Review12:06 13-Dec-24
    Center for Biosimilars23:16 10-Dec-24
    Business Wire (Press Release)13:27 10-Dec-24
    Yonhap News Agency05:23 10-Dec-24
    Korea JoongAng Daily18:58 9-Dec-24
    The Korea Herald16:02 9-Dec-24
    Korea JoongAng Daily19:24 5-Dec-24
    The Korea Herald15:47 5-Dec-24
    JD Supra04:26 5-Dec-24
    BioWorld06:52 4-Dec-24
    Korea JoongAng Daily19:25 3-Dec-24
    Korea Biomedical Review13:04 3-Dec-24
    The Korea Herald19:32 2-Dec-24
    Center for Biosimilars23:16 30-Nov-24
    Scrip Pharma Intelligence17:30 29-Nov-24
    Korea Biomedical Review13:31 28-Nov-24
    Korea Biomedical Review11:17 28-Nov-24
    Korea JoongAng Daily22:01 27-Nov-24
    Korea Biomedical Review20:19 27-Nov-24
    BioWorld08:11 23-Nov-24
    Korea Biomedical Review19:26 22-Nov-24
    The Korea Herald16:20 22-Nov-24
    view more headlines
    19 Dec 04:07

    About our Celltrion news

    Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.